Fresenius Medical Care Discontinued
FDA Approved Drugs

Fresenius Medical Care Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 8
  • Latest Approval Date Jun 02, 2020
  • Data Source FDA
  • First Approval Date Jan 01, 1982
All
11
View
Discontinued
8
View
RX
3
View
Company Overview

Company

Fresenius Medical Care Discontinued

Country

Mexico

Website

Visit Website

Email

Social Profiles

LinkedIn
Company Snapshot

Fresenius Medical Care Discontinued

Torre Mural, Insurgentes Sur 1605 Floor 29, Col. San José Insurgentes. CP 03900, Del. Benito Juárez

Mexico

www.freseniusmedicalcare.com/en/home View on Map
FDA Approved Drug Records ( 8 records )
1994
13 Jun
Discontinued Application: 20374

Drug Name

INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

Product Number

1

Dosage Form

-

Strength

18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

Approval Date

1994-06-13

20374 / 1

Active Ingredient

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Application Number

20374

Product Number

1

Dosage Form

-

Strength

18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

Approval Date

1994-06-13

Regulatory Status

Discontinued

1994
13 Jun
Discontinued Application: 20374

Drug Name

INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

Product Number

2

Dosage Form

-

Strength

18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

Approval Date

1994-06-13

20374 / 2

Active Ingredient

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Application Number

20374

Product Number

2

Dosage Form

-

Strength

18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

Approval Date

1994-06-13

Regulatory Status

Discontinued

1994
13 Jun
Discontinued Application: 20374

Drug Name

INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER

Product Number

3

Dosage Form

-

Strength

18.4MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

Approval Date

1994-06-13

20374 / 3

Active Ingredient

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Application Number

20374

Product Number

3

Dosage Form

-

Strength

18.4MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

Approval Date

1994-06-13

Regulatory Status

Discontinued

1994
13 Jun
Discontinued Application: 20374

Drug Name

INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

Product Number

4

Dosage Form

-

Strength

18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

Approval Date

1994-06-13

20374 / 4

Active Ingredient

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Application Number

20374

Product Number

4

Dosage Form

-

Strength

18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

Approval Date

1994-06-13

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 17643

Drug Name

INTRALIPID 10%

Product Number

1

Dosage Form

-

Strength

10%

Approval Date

1982-01-01

17643 / 1

Active Ingredient

SOYBEAN OIL

Application Number

17643

Product Number

1

Dosage Form

-

Strength

10%

Approval Date

1982-01-01

Regulatory Status

Discontinued

2019
10 Dec
Discontinued Application: 206682

Drug Name

NAFCILLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2019-12-10

206682 / 1

Active Ingredient

NAFCILLIN SODIUM

Application Number

206682

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2019-12-10

Regulatory Status

Discontinued

2019
10 Dec
Discontinued Application: 206682

Drug Name

NAFCILLIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2019-12-10

206682 / 2

Active Ingredient

NAFCILLIN SODIUM

Application Number

206682

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2019-12-10

Regulatory Status

Discontinued

2020
02 Jun
Discontinued Application: 206761

Drug Name

NAFCILLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2020-06-02

206761 / 1

Active Ingredient

NAFCILLIN SODIUM

Application Number

206761

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2020-06-02

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    3 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    11 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
8 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

Application Number

20374

Product Number

1

Active Ingredient

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Dosage Form

-

Strength

18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit